GT200300176A - IMMUNE STIMULATING NUCLEIC ACIDS - Google Patents

IMMUNE STIMULATING NUCLEIC ACIDS

Info

Publication number
GT200300176A
GT200300176A GT200300176A GT200300176A GT200300176A GT 200300176 A GT200300176 A GT 200300176A GT 200300176 A GT200300176 A GT 200300176A GT 200300176 A GT200300176 A GT 200300176A GT 200300176 A GT200300176 A GT 200300176A
Authority
GT
Guatemala
Prior art keywords
nucleic acids
immune stimulating
stimulating nucleic
variety
immune
Prior art date
Application number
GT200300176A
Other languages
Spanish (es)
Inventor
Arthur M Krieg
Ulrike Samulowitz
Joerg Vollmer
Eugen Uhlmann
Marion Jurk
Grayson Lipford
Robert Rankin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200300176A publication Critical patent/GT200300176A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A ACIDOS NUCLEICOS INMUNOESTIMULADORES CPG BLANDOS O SEMIBLADOS QUE VAN A INDUCIR UNA RESPUESTA INMUNE DE TIPO TH1 POR LO QUE SON DE UTILIDAD COMO ADYUVANTES PARA VACUNACION Y UNA AMPLIA VARIEDAD DE PATOLOGIAS TALES COMO EL CANCER, ASMA Y VARIEDAD DE ALERGIAS, ENTRE OTRAS DESCRITAS EN LA SOLICITUD.THE PRESENT INVENTION REFERS TO WHITE OR SEMIBLED CPG IMMUNOSTIMULATING NUCLETIC ACIDS THAT ARE TO INDUCIATE AN IMMUNE TH1 TYPE RESPONSE FOR WHICH THEY ARE USEFUL AS A VACCINATION ASSISTANT AND A VARIETY OF VARIETY, VARIOUS ASSOCIATIONS, VARIATIONS BETWEEN OTHER DESCRIBED IN THE APPLICATION.

GT200300176A 2002-08-19 2003-08-19 IMMUNE STIMULATING NUCLEIC ACIDS GT200300176A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40447902P 2002-08-19 2002-08-19

Publications (1)

Publication Number Publication Date
GT200300176A true GT200300176A (en) 2004-03-29

Family

ID=35306229

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200300176A GT200300176A (en) 2002-08-19 2003-08-19 IMMUNE STIMULATING NUCLEIC ACIDS

Country Status (5)

Country Link
CN (1) CN1688192B (en)
GT (1) GT200300176A (en)
TN (1) TNSN05052A1 (en)
UA (1) UA88255C2 (en)
ZA (1) ZA200500963B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102864152B (en) * 2005-11-07 2015-11-18 艾德拉药物股份有限公司 Comprise the immunostimulatory properties of the compound based on oligonucleotide of modified immunostimulating dinucleotides
KR101251707B1 (en) * 2006-09-27 2013-04-11 콜리 파마슈티칼 게엠베하 CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity
EP2620428B1 (en) 2010-09-24 2019-05-22 Wave Life Sciences Ltd. Asymmetric auxiliary group
CA2879066C (en) * 2012-07-13 2019-08-13 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant
MY175308A (en) * 2013-05-18 2020-06-18 Aduro Biotech Inc Compositions and methods for activating "stimulator of interferon gene"-dependent signalling

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1271733A (en) * 2000-04-04 2000-11-01 中国预防医学科学院病毒学研究所 CpG oligonucleotide with specific immunostimulation activity to human immune cell

Also Published As

Publication number Publication date
TNSN05052A1 (en) 2007-05-14
UA88255C2 (en) 2009-10-12
CN1688192A (en) 2005-10-26
ZA200500963B (en) 2006-10-25
CN1688192B (en) 2012-07-18

Similar Documents

Publication Publication Date Title
GT200500294A (en) SEMIBLING C-CLASS IMMUNO-STIMULATOR OLIGONUCLEOTIDES
UY27945A1 (en) IMMUNE STIMULATING NUCLEIC ACIDS
CL2018000319A1 (en) Oil based adjuvants (application division 201600650)
MY137619A (en) 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
EA201300585A1 (en) Immunomodulatory Oligonucleotides
EA201700181A1 (en) COMPOSITIONS OF ADENOSINDEMINASE-2 (ADA-2), THEIR OPTIONS AND METHODS OF USE
IN2014DN05848A (en)
CR8423A (en) CLASS C NUCLEOTID ANALOGS WITH IMPROVED IMMUNO-STIMULATING POWER
ATE451388T1 (en) TUMOR-ASSOCIATED PEPTIDES THAT BIND PROMISCUITIVELY TO CLASS II HUMAN LEUKOCYTE ANTIGEN (HLA) MOLECULES
ATE426412T1 (en) ADJUVANT INFLUENZA VACCINE
UY33297A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A POLYPEPTIDE THAT UNDERSTANDS AT LEAST A CXXC REASON AND HETEROLOGICAL ANTIGENS AND USES OF THE SAME
CU23819A3 (en) MUCOSAL IMMUNOGENIC SUBSTANCES UNDERSTANDING A POLYINOSINIC ACID-POLYTIDYLIC ACID BASE
SG167667A1 (en) Nucleic acid compositions for stimulating immune responses
MX2009004243A (en) Novel h5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use.
CL2009001195A1 (en) Immune adjuvant comprising an iap inhibitor capable of modulating immune activity; pharmaceutical composition and vaccine comprising it; method of enhancing an immune response of an individual; method of treating cancer in an individual; method of treating infection; method of treating autoimmune disorders.
WO2016179034A3 (en) Methods and compositions for stimulating immune response using potent immunostimulatory rna motifs
CL2020001561A1 (en) Immunostimulating compositions.
MX2021015972A (en) Foot-and-mouth disease vaccine.
UY36990A (en) DERIVATIVES OF ANTIBODIES AGAINST HIV WITH DUAL ANTIVIRAL AND IMMUNOMODULATORY ACTIVITY
WO2012054907A3 (en) Novel hemagglutinin 5 (h5) proteins for the treatment and prevention of influenza infections
GT200300176A (en) IMMUNE STIMULATING NUCLEIC ACIDS
AU2003229434A8 (en) Cancer vaccines and methods of using the same
CR11384A (en) STREPTOCOCO PROTEIN M, IMMUNOGENIC FRAGMENTS, NUCLEIC ACIDS AND METHODS OF USE
EA201200538A1 (en) ARABINOGALAKTAN TO IMPROVE ACQUIRED IMMUNE RESPONSE
WO2007120860A3 (en) Nanoemulsion vaccines